Cargando…
Early-Pregnancy Dydrogesterone Supplementation Mimicking Luteal-Phase Support in ART Patients Did Not Provoke Major Reproductive Disorders in Pregnant Mice and Their Progeny
Progestogens are frequently administered during early pregnancy to patients undergoing assisted reproductive techniques (ART) to overcome progesterone deficits following ART procedures. Orally administered dydrogesterone (DG) shows equal efficacy to other progestogens with a higher level of patient...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161261/ https://www.ncbi.nlm.nih.gov/pubmed/34065597 http://dx.doi.org/10.3390/ijms22105403 |
_version_ | 1783700468767129600 |
---|---|
author | Jeschke, Laura Santamaria, Clarisa Guillermina Meyer, Nicole Zenclussen, Ana Claudia Bartley, Julia Schumacher, Anne |
author_facet | Jeschke, Laura Santamaria, Clarisa Guillermina Meyer, Nicole Zenclussen, Ana Claudia Bartley, Julia Schumacher, Anne |
author_sort | Jeschke, Laura |
collection | PubMed |
description | Progestogens are frequently administered during early pregnancy to patients undergoing assisted reproductive techniques (ART) to overcome progesterone deficits following ART procedures. Orally administered dydrogesterone (DG) shows equal efficacy to other progestogens with a higher level of patient compliance. However, potential harmful effects of DG on critical pregnancy processes and on the health of the progeny are not yet completely ruled out. We treated pregnant mice with DG in the mode, duration, and doses comparable to ART patients. Subsequently, we studied DG effects on embryo implantation, placental and fetal growth, fetal-maternal circulation, fetal survival, and the uterine immune status. After birth of in utero DG-exposed progeny, we assessed their sex ratios, weight gain, and reproductive performance. Early-pregnancy DG administration did not interfere with placental and fetal development, fetal-maternal circulation, or fetal survival, and provoked only minor changes in the uterine immune compartment. DG-exposed offspring grew normally, were fertile, and showed no reproductive abnormalities with the exception of an altered spermiogram in male progeny. Notably, DG shifted the sex ratio in favor of female progeny. Even though our data may be reassuring for the use of DG in ART patients, the detrimental effects on spermatogenesis in mice warrants further investigations and may be a reason for caution for routine DG supplementation in early pregnancy. |
format | Online Article Text |
id | pubmed-8161261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81612612021-05-29 Early-Pregnancy Dydrogesterone Supplementation Mimicking Luteal-Phase Support in ART Patients Did Not Provoke Major Reproductive Disorders in Pregnant Mice and Their Progeny Jeschke, Laura Santamaria, Clarisa Guillermina Meyer, Nicole Zenclussen, Ana Claudia Bartley, Julia Schumacher, Anne Int J Mol Sci Article Progestogens are frequently administered during early pregnancy to patients undergoing assisted reproductive techniques (ART) to overcome progesterone deficits following ART procedures. Orally administered dydrogesterone (DG) shows equal efficacy to other progestogens with a higher level of patient compliance. However, potential harmful effects of DG on critical pregnancy processes and on the health of the progeny are not yet completely ruled out. We treated pregnant mice with DG in the mode, duration, and doses comparable to ART patients. Subsequently, we studied DG effects on embryo implantation, placental and fetal growth, fetal-maternal circulation, fetal survival, and the uterine immune status. After birth of in utero DG-exposed progeny, we assessed their sex ratios, weight gain, and reproductive performance. Early-pregnancy DG administration did not interfere with placental and fetal development, fetal-maternal circulation, or fetal survival, and provoked only minor changes in the uterine immune compartment. DG-exposed offspring grew normally, were fertile, and showed no reproductive abnormalities with the exception of an altered spermiogram in male progeny. Notably, DG shifted the sex ratio in favor of female progeny. Even though our data may be reassuring for the use of DG in ART patients, the detrimental effects on spermatogenesis in mice warrants further investigations and may be a reason for caution for routine DG supplementation in early pregnancy. MDPI 2021-05-20 /pmc/articles/PMC8161261/ /pubmed/34065597 http://dx.doi.org/10.3390/ijms22105403 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jeschke, Laura Santamaria, Clarisa Guillermina Meyer, Nicole Zenclussen, Ana Claudia Bartley, Julia Schumacher, Anne Early-Pregnancy Dydrogesterone Supplementation Mimicking Luteal-Phase Support in ART Patients Did Not Provoke Major Reproductive Disorders in Pregnant Mice and Their Progeny |
title | Early-Pregnancy Dydrogesterone Supplementation Mimicking Luteal-Phase Support in ART Patients Did Not Provoke Major Reproductive Disorders in Pregnant Mice and Their Progeny |
title_full | Early-Pregnancy Dydrogesterone Supplementation Mimicking Luteal-Phase Support in ART Patients Did Not Provoke Major Reproductive Disorders in Pregnant Mice and Their Progeny |
title_fullStr | Early-Pregnancy Dydrogesterone Supplementation Mimicking Luteal-Phase Support in ART Patients Did Not Provoke Major Reproductive Disorders in Pregnant Mice and Their Progeny |
title_full_unstemmed | Early-Pregnancy Dydrogesterone Supplementation Mimicking Luteal-Phase Support in ART Patients Did Not Provoke Major Reproductive Disorders in Pregnant Mice and Their Progeny |
title_short | Early-Pregnancy Dydrogesterone Supplementation Mimicking Luteal-Phase Support in ART Patients Did Not Provoke Major Reproductive Disorders in Pregnant Mice and Their Progeny |
title_sort | early-pregnancy dydrogesterone supplementation mimicking luteal-phase support in art patients did not provoke major reproductive disorders in pregnant mice and their progeny |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161261/ https://www.ncbi.nlm.nih.gov/pubmed/34065597 http://dx.doi.org/10.3390/ijms22105403 |
work_keys_str_mv | AT jeschkelaura earlypregnancydydrogesteronesupplementationmimickinglutealphasesupportinartpatientsdidnotprovokemajorreproductivedisordersinpregnantmiceandtheirprogeny AT santamariaclarisaguillermina earlypregnancydydrogesteronesupplementationmimickinglutealphasesupportinartpatientsdidnotprovokemajorreproductivedisordersinpregnantmiceandtheirprogeny AT meyernicole earlypregnancydydrogesteronesupplementationmimickinglutealphasesupportinartpatientsdidnotprovokemajorreproductivedisordersinpregnantmiceandtheirprogeny AT zenclussenanaclaudia earlypregnancydydrogesteronesupplementationmimickinglutealphasesupportinartpatientsdidnotprovokemajorreproductivedisordersinpregnantmiceandtheirprogeny AT bartleyjulia earlypregnancydydrogesteronesupplementationmimickinglutealphasesupportinartpatientsdidnotprovokemajorreproductivedisordersinpregnantmiceandtheirprogeny AT schumacheranne earlypregnancydydrogesteronesupplementationmimickinglutealphasesupportinartpatientsdidnotprovokemajorreproductivedisordersinpregnantmiceandtheirprogeny |